E-mails
- ANTI-8-OXO ADENOSINE DNA/RNA DAMAGE New Benchmark Antibodies for Oxidative Nucleic Acid Damage - 8-oxoA and 8-OHG
- Interest in Estrogen Receptor (ER) at AACR 2025
- Interest in CDK4 at AACR 2025
- Interest in Topoisomerase at AACR 2025
- Interest in Ki-67 at AACR 2025
- Interest in BRCA1 at AACR 2025
- Interest in SF1 at AACR 2025
- Interest in pgp9.5 at AACR 2025
- Interest in GH at AACR 2025
- Interest in PTH at AACR 2025
- Interest in p53 at AACR 2025
- Interest in NKX3.1 at AACR 2025
- Interest in NKX2.2 at AACR 2025
- Interest in Factor XIII at AACR 2025
- Interest in EP-CAM at AACR 2025
- Interest in Cytokeratin 5 at AACR 2025
- Interest in CD4 at AACR 2025
- Interest in CD3 at AACR 2025
- Interest in CA-IX at AACR 2025
- Interest in EGFR at AACR 2025
- Interest in c-myc at AACR 2025
- Interest in CD8 at AACR 2025
- Interest in androgen receptor at AACR 2025
- Interest in e-cadherin at AACR 2025
- Interest in PD-L1 at AACR 2025
- Virion Serion kits at benchmark antibodies - Brucella April 2025
- Virion Serion kits at benchmark antibodies - Yersinia April 2025
- Virion Serion kits at benchmark antibodies - March 2025
- Virion Serion kits at benchmark antibodies - tetanus March 2025